Overview

Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the cardiac safety of TAS-102 in patients with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Taiho Oncology, Inc.
Treatments:
Trifluridine